SACCO, Marco
 Distribuzione geografica
Continente #
NA - Nord America 1445
EU - Europa 953
AS - Asia 571
SA - Sud America 23
AF - Africa 15
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3018
Nazione #
US - Stati Uniti d'America 1410
CN - Cina 414
DE - Germania 274
IT - Italia 185
IE - Irlanda 98
SE - Svezia 83
FR - Francia 61
GB - Regno Unito 42
AT - Austria 37
VN - Vietnam 33
ES - Italia 32
JP - Giappone 30
BE - Belgio 28
UA - Ucraina 27
IN - India 25
CA - Canada 23
BR - Brasile 17
FI - Finlandia 16
DK - Danimarca 13
HK - Hong Kong 13
KR - Corea 12
PL - Polonia 12
RO - Romania 12
ID - Indonesia 11
AU - Australia 10
MX - Messico 10
UZ - Uzbekistan 8
CV - Capo Verde 6
EG - Egitto 6
NO - Norvegia 6
RU - Federazione Russa 6
TW - Taiwan 6
GR - Grecia 5
PH - Filippine 4
PT - Portogallo 4
TH - Thailandia 4
AR - Argentina 3
CH - Svizzera 2
CO - Colombia 2
CZ - Repubblica Ceca 2
IL - Israele 2
LY - Libia 2
MY - Malesia 2
NL - Olanda 2
SG - Singapore 2
TR - Turchia 2
BG - Bulgaria 1
BY - Bielorussia 1
CL - Cile 1
CU - Cuba 1
EU - Europa 1
GN - Guinea 1
HN - Honduras 1
HU - Ungheria 1
IQ - Iraq 1
IR - Iran 1
LU - Lussemburgo 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 3018
Città #
Chandler 292
Ann Arbor 143
Beijing 128
Dublin 98
Fairfield 77
Fremont 71
Nyköping 62
Torino 57
Redwood City 55
Woodbridge 45
Villeurbanne 44
Dearborn 39
Shanghai 39
Wilmington 39
Houston 36
Vienna 36
Cambridge 31
Guangzhou 30
Princeton 30
Nanjing 27
Medford 25
Ashburn 23
Jacksonville 23
Brussels 19
Chengdu 17
Dong Ket 17
Hangzhou 17
Seattle 15
Pisa 14
Zhengzhou 14
Boston 13
Tokyo 13
Milan 12
Nürnberg 10
Wuhan 10
Jakarta 9
Ottawa 9
Bucharest 8
London 8
San Diego 7
Buffalo 6
Duncan 6
Kunming 6
Mountain View 6
Nanchang 6
Norwalk 6
Odense 6
Turin 6
Warsaw 6
Bologna 5
Changchun 5
Friedrichsdorf 5
Los Angeles 5
Ningbo 5
Seoul 5
Bergen 4
Changsha 4
Chennai 4
Hebei 4
Shenyang 4
Silver Spring 4
Tong 4
Upper Marlboro 4
Valladolid 4
Vilassar de Mar 4
Antwerpen 3
Bangalore 3
Barcelona 3
Berlin 3
Central District 3
Copenhagen 3
Guiyang 3
Hanoi 3
Hefei 3
Lake Mary 3
Lund 3
Madrid 3
New Haven 3
Osaka 3
Padova 3
San Mateo 3
Scottville 3
Taipei 3
Toronto 3
Walnut Creek 3
Xian 3
Aachen 2
Athens 2
Augsburg 2
Birmingham 2
Boardman 2
Brisbane 2
Buenos Aires 2
Charleston 2
Chicago 2
Curitiba 2
Dallas 2
Dresden 2
Duisburg 2
Düsseldorf 2
Totale 1877
Nome #
Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease 622
DURABILITY OF THE RESPONSE TO PEGINTERFERON ALFA2b AND RIBAVIRIN IN CHRONIC HEPATITIS C PATIENTS: A COHORT STUDY IN THE ROUTINE CLINICAL SETTING. 307
Impact of viral eradication with sofosbuvir-based therapy on the outcome of post-transplant hepatitis C with severe fibrosis 292
Significant improvement of glycemic control in diabetic patients with HCV infection responding to direct-acting antiviral agents 243
Differential diagnosis of pancreatic cysts: A prospective study on the role of intra-cystic glucose concentration 206
SOFOSBUVIR PLUS RIBAVIRIN IN PATIENTS WITH SEVERE HCV RECURRENCE AFTER LIVER TRANSPLANTATION: A SINGLE CENTRE EXPERIENCE 107
ALL ORAL SOFOSBUVIR-BASED ANTIVIRAL THERAPY IN LIVER TRANSPLANT RECIPIENTS AFFECTED BY MODERATE-SEVERE HEPATITIS C RECURRENCE: PREDICTORS OF VIRAL RESPONSE AND SURVIVAL 103
SOFOSBUVIR PLUS RIBAVIRIN BEFORE OR ACROSS LIVER TRANSPLANTATION TO PREVENT HCV RECURRENCE: A SINGLE CENTRE EXPERIENCE 96
The Effect of Viral Clearance Achieved by Direct-Acting Antiviral Agents on Hepatitis C Virus Positive Patients with Type 2 Diabetes Mellitus: A Word of Caution after the Initial Enthusiasm 96
Negativization of viremia prior to liver transplant reduces early allograft dysfunction in hepatitis C recipients 94
FEASIBILITY AND EFFICACY OF SOFOSBUVIR-BASED ANTIVIRAL THERAPY BEFORE LIVER TRANSPLANTATION TO PREVENT HCV RECURRENCE: A MONOCENTRIC EXPERIENCE 91
SOFOSBUVIR PLUS RIBAVIRIN FOR THE TREATMENT OF SEVERE HCV RECURRENCE AFTER LIVER TRANSPLANTATION: PRELIMINARY DATA FROM A SINGLE-CENTRE EXPERIENCE 90
Antiviral Therapy With Sofosbuvir Plus Ribavirin Before Or Across Liver Transplantation To Prevent HCV Recurrence: Preliminary Data from a Single Centre Experience 82
ANTIVIRAL THERAPY WITH SOFOSBUVIR PLUS RIBAVIRIN IN HCV-INFECTED CIRRHOTIC PATIENTS AWAITING LIVER TRANSPLANTATION: PRELIMINARY DATA FROM A SINGLE-CENTRE EXPERIENCE 81
SAFETY AND EFFICACY OF SOFOSBUVIR-BASED ANTIVIRAL THERAPY IMMEDIATELY AFTER LIVER TRANSPLANTATION: A MATCHED CASE-CONTROL ANALYSIS 77
Type 2 diabetes mellitus and chronic hepatitis C: Which is worse? Results of a long-term retrospective cohort study. 75
ANTIVIRAL THERAPY WITH SOFOSBUVIR PLUS RIBAVIRIN FOR THE TREATMENT OF SEVERE HCV RECURRENCE AFTER LIVER TRANSPLANTATION: PRELIMINARY DATA FROM A SINGLE-CENTRE EXPERIENCE 69
Effect of COVID-19 pandemic on the workflow of endoscopy units: an international survey 63
Impact of IL28B genotype on response rates in hepatitis C virus cirrhotic patients treated with new DAA regimens: experience of a single center 62
SOFOSBUVIR PLUS RIBAVIRIN IN HCV-INFECTED CIRRHOTIC PATIENTS AWAITING LIVER TRANSPLANTATION: PRELIMINARY DATA FROM A SINGLE-CENTRE EXPERIENCE 54
Long-term follow-up of diabetic and non-diabetic patients with chronic hepatitis C successfully treated with direct-acting antiviral agents 49
Long-term follow-up of diabetic and non-diabetic patients with chronic hepatitis C 46
Impact of Macroscopic On-Site Evaluation (MOSE) on Accuracy of Endoscopic Ultrasound-Guided Fine-Needle Biopsy (EUS-FNB) of Pancreatic and Extrapancreatic Solid Lesions: A Prospective Study 44
The impact of direct-acting antiviral treatment on glycemic homeostasis in patients with chronic hepatitis C 38
Screening and surveillance of esophageal varices in patients with HCV-positive liver cirrhosis successfully treated by direct acting antiviral agents 28
Malignant duodenocolic fistula successfully treated with self-expandable partially covered metal stent and endoscopic suturing 5
Who Should Not Be Surveilled for HCC Development after Successful Therapy with DAAS in Advanced Chronic Hepatitis C? Results of a Long-Term Prospective Study 4
Incidence, risk and protective factors of symptoms after colonoscopy 3
EUS-FNB OF AN UPPER MEDIASTINAL TUMOR 3
Hepatorenal syndrome after treatment of visceral leishmaniasis requiring terlipressin therapy 3
EUS-GUIDED DIAGNOSIS OF SUBEPITHELIAL GASTROINTESTINAL LESIONS: A MONOCENTRIC EXPERIENCE IN THE ERA OF THE NEW FNB NEEDLES 2
Determinants of symptom burden related to bowel preparation for colonoscopy 2
MINIMAL RESIDUAL INTRAHEPATIC LITHIASIS TREATED WITH INTRADUCTAL LITHOTRIPSY 2
A transvalvular polypectomy of a giant ileal inflammatory fibroid polyp by retrograde single-balloon enteroscopy 2
Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide 2
What surgeons should know about endoscopic ultrasonography 1
A case of persistent iron deficiency anemia in a kidney transplant recipient 1
Predictors of adverse events after endoscopic ultrasound-guided through-The-needle biopsy of pancreatic cysts: A recursive partitioning analysis 1
A comment on Helicobacter pylori and rosacea 1
Totale 3147
Categoria #
all - tutte 5810
article - articoli 0
book - libri 0
conference - conferenze 2031
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7841


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/20188 0000 00 00 0008
2018/2019200 871118 1418 1428 11312614
2019/2020303 1491328 1736 3523 40401830
2020/2021523 21413433 5049 4352 38554562
2021/2022731 27425030 5366 8580 574410097
2022/2023806 80854370 81138 6059 9230680
Totale 3147